Ideaya Biosciences

This study is testing whether a drug called IDE196 (darovasertib) can help control eye melanoma when given before and sometimes after standard treatments like radiation or eye removal. Researchers want to see if the drug shrinks tumors enough to avoid removing the eye, reduces ra…

This clinical trial is testing whether a new two-drug combination (IDE196 plus crizotinib) works better than current standard treatments for metastatic uveal melanoma, a rare but aggressive eye cancer that has spread. The study will enroll 420 patients who are HLA-A2 negative and…